Envista Holdings Corp (NVST) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Envista Holdings Corp stock (NVST) is currently trading at $26.14. Envista Holdings Corp PE ratio is 92.96. Envista Holdings Corp PS ratio (Price-to-Sales) is 1.57. Analyst consensus price target for NVST is $28.67. WallStSmart rates NVST as Hold.
- NVST PE ratio analysis and historical PE chart
- NVST PS ratio (Price-to-Sales) history and trend
- NVST intrinsic value — DCF, Graham Number, EPV models
- NVST stock price prediction 2025 2026 2027 2028 2029 2030
- NVST fair value vs current price
- NVST insider transactions and insider buying
- Is NVST undervalued or overvalued?
- Envista Holdings Corp financial analysis — revenue, earnings, cash flow
- NVST Piotroski F-Score and Altman Z-Score
- NVST analyst price target and Smart Rating
Envista Holdings Corp
📊 No data available
Try selecting a different time range
NVST Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Envista Holdings Corp (NVST)
NVST trades 131% above its Graham fair value of $13.10, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Envista Holdings Corp (NVST) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, eps growth. Concerns around return on equity and profit margin. Fundamentals are solid but monitor weak areas for improvement.
Envista Holdings Corp (NVST) Key Strengths (5)
Earnings per share surging 3146.00% year-over-year
113.04% of shares held by major funds and institutions
Paying $1.57 for every $1 of annual revenue
Trading at 1.36x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Envista Holdings Corp (NVST) Areas to Watch (4)
Very low returns on shareholder equity
Very thin margins, barely profitable
Thin operating margins with cost pressures present
Solid revenue growth at 15.00% per year
Supporting Valuation Data
Envista Holdings Corp (NVST) Detailed Analysis Report
Overall Assessment
This company scores 56/100 in our Smart Analysis, earning a C grade. Out of 9 metrics analyzed, 5 register as strengths (avg 8.6/10) while 4 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.57), Price/Book (1.36) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 3146.00%.
The Bear Case
The primary concerns are Return on Equity, Profit Margin, Operating Margin. Growth concerns include Revenue Growth at 15.00%, which may limit upside. Profitability pressure is visible in Return on Equity at 1.56%, Operating Margin at 10.70%, Profit Margin at 1.73%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 1.56% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 15.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (EPS Growth, Institutional Own.) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NVST Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NVST's Price-to-Sales ratio of 1.57x sits near its historical average of 1.6x (29th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 11% below its historical high of 1.77x set in Mar 2026, and 6% above its historical low of 1.49x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.8x as trailing revenue scaled faster than the stock price.
Compare NVST with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Envista Holdings Corp (NVST) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Envista Holdings Corp operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2.7B with 15% growth year-over-year. Profit margins are thin at 1.7%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 92M in free cash flow and 108M in operating cash flow. Earnings are translating into actual cash generation.
ROE of 1.6% suggests the company isn't efficiently converting equity into profits.
What to Watch Next
Margin expansion: can Envista Holdings Corp push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 93.0x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Envista Holdings Corp.
Bottom Line
Envista Holdings Corp offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(43 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 11:30:25 AM
About Envista Holdings Corp(NVST)
NYSE
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.